ArticleMicrocirculation (New York, N.Y. : 1994)2026
DangGuiSiNi Decoction and QiShenYiQi Pills Ameliorate Hyperpermeability and Edema Induced by Cold Exposure.
Article in Microcirculation (New York, N.Y. : 1994), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveLimb frostbite caused by cold exposure is a prevalent injury in winter. However, effective therapies remain limited, particularly for cold-induced edema. This study evaluated the therapeutic potential of DangGuiSiNi Decoction (DSD), QiShenYiQi Pills (QSYQ), and their combination in a rat model of cold-induced limb injury.
methodsMale Sprague-Dawley rats (180-220 g) were subjected to hind limb frostbite through 5-min dry ice exposure. Animals were administered with DSD, QSYQ, or their combination via oral gavage either 2 h pre-exposure or 5 min post-exposure, followed by daily dosing for 7 days. Hennepin Score, hind limb blood flow, FITC-albumin extravasation, rhodamine 6G-labeled leukocyte adhesion, expression of tight/adhesion junction proteins and basement membrane components, transient receptor potential (TRP) channel proteins, ATP content, and norepinephrine levels at 2 h, 24 h, and 7 days post-exposure were assessed.
resultsThe combination of DSD and QSYQ significantly alleviated frostbite-induced edema and gangrene. Compared with control group, cold exposure increased the expression of TRPA1, TRPM8, RhoA, ROCK, p-MLC, adrenergic receptor α2c and norepinephrine content, while decreased the expression of tight and adherent junction proteins claudin-5, ZO-1, JAM-1, basement membrane proteins laminin and collagen-IV, ATP content, and the activity of mitochondrial complex I, II, IV and V. DSD primarily counteracted the cold-sensing and vasoconstrictive pathways by reducing TRPA1/TRPM8 expression, norepinephrine levels, and RhoA/ROCK activation, thereby improving blood flow. In contrast, QSYQ enhanced vascular barrier integrity by upregulating junction and basement membrane proteins, and boosted energy supply by increasing ATP content and mitochondrial complex activities. The combination of DSD and QSYQ produced aggregated therapeutic effects.
conclusionDSD attenuates frostbite by inhibiting temperature-sensing and vasoconstrictive pathways to ameliorate ischemia, whereas QSYQ protects vascular barrier function and mitigates edema by restoring energy metabolism. Their combination exhibits complementary and synergistic effects, supporting its use as a promising adjunctive therapy for cold-induced injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.